Terry Chrisomalis | TalkMarkets | Page 2

Terry Chrisomalis

Contributor's Links: Biotechpicklist SeekingAlpha
I am a graduate of Business Administration and have created my own Pharmaceutical website "BiotechPicklist.com". I have been investing and writing about biotechnology stocks for 5 years now and have extensive experience writing about the science and companies themselves. I am a Seeking ...more
Following: 31 Followers: 123

Articles

Latest Posts
17 to 32 of 55 Posts
<<< 1 2 3 4 >>>
Inovio Pharmaceuticals: Partnerships Keep Rolling In
Tuesday, October 21, 2014 1:32 PM EDT
Inovio Pharmaceuticals partners with MedImmune to create monoclonal antibodies against various infections.
In this article: AZN, INO, RHHBY
Read
Northwest Biotherapeutics: A Variety Of Possibilities With The Future Of Immunotherapy Treatments
Tuesday, October 21, 2014 10:18 AM EDT
Northwest Biotherapeutic's recent news suggests a great buying opportunity.
In this article: NWBO
Read
NewLink Genetics Scores Big Partnership Deal With Roche
Monday, October 20, 2014 10:10 AM EDT
NewLink Genetics to co-develop cancer drug with Roche. Great news for NewLink.
In this article: RHHBY, NLNK
Read
Tekmira Reports Early Results On Hepatitis B Drug
Wednesday, October 15, 2014 4:52 PM EDT
Tekmira reports pre-clinical results on Hepatitis B drug
In this article: BMY, TKMR
Read
Alnylam Keeps Making New Strides In RNAi Research
Tuesday, October 14, 2014 3:46 PM EDT
Alnylam posts positive phase 2 results in open-label study.
In this article: SNY, ALNY, TKMR
Read
Arrowhead Drops On Phase 2 Hepatitis B Results, Opportunity To Buy Shares
Friday, October 10, 2014 10:04 AM EDT
Arrowhead Research Corp tumbles on Hepatitis B data
In this article: ARWR
Read
RXi Pharmaceuticals Posts Positive Phase 2a 3-Month Results In Hypertrophic Scars
Tuesday, October 7, 2014 3:13 PM EDT
This validation is important because now the company is at a reduced risk investment level.
In this article: TKMR, ARWR, RXII
Read
Clovis Oncology Should Not Be Ignored
Tuesday, September 30, 2014 6:10 PM EDT
Clovis announces positive Phase 2 results In Ovarian Cancer patients
In this article: CLVS
Read
Inovio Pharma Wants To Join The Ebola Party
Wednesday, September 24, 2014 10:33 PM EDT
Inovio Pharmaceuticals To Begin Ebola Vaccine Study in early 2015
In this article: INO, TKMR
Read
Tekmira Pharmaceuticals Just Keeps On Shining With Ebola Drug
Tuesday, September 23, 2014 5:25 PM EDT
Tekmira surges on back to back news for Ebola drug, but that's not all the company has going for it.
In this article: TKMR
Read
Rexahn Pharmaceuticals Looks To Find A New Partner Once Again For Cancer Compound
Tuesday, September 16, 2014 7:29 PM EDT
Now that Rexahn's partnership with Teva fell apart, it appears the company is looking for a new partner for its RX-3117 cancer compound.
In this article: RNN, TEVA
Read
Rxi Pharmaceuticals Presents Preliminary Phase 2 Data In Hypertrophic Scars, Share Price Unfairly Punished
Wednesday, September 10, 2014 9:10 PM EDT
Rxi Pharmaceuticals posts initial phase 2a preliminary data in hypertrophic scars.
In this article: RXII
Read
Rxi Pharmaceuticals Is Ready To Show The True Power Of Its Technology Platform
Wednesday, September 3, 2014 9:15 PM EDT
Rxi Pharmaceuticals to Showcase phase 2a hypertrophic scar Results and other data
In this article: AGN, TKMR, ARWR, RXII
Read
Looking Into Tonix Pharmaceuticals Before Phase 2b Fibromyalgia Results
Friday, August 29, 2014 4:40 PM EDT
Tonix Pharmaceuticals has a big catalyst for investors in Q4 2014
In this article: TNXP
Read
Roche Wastes No Time, Acquires Intermune For $8.3 Billion Dollars
Tuesday, August 26, 2014 4:19 PM EDT
Roche deal spurs merger and acquisition activity across the biotech industry.
In this article: RHHBY, ACHN, ITMN, ARWR, RXII
Read
Achillion Pharmaceuticals Is Primed For An Eventual Buyout
Tuesday, August 19, 2014 11:49 AM EDT
Achillion Pharmaceuticals will eventually be bought out by a big pharmaceutical company
In this article: ACHN, GILD
Read
17 to 32 of 55 Posts
<<< 1 2 3 4 >>>